RD
Ravimohan Dhavala
About Ravimohan Dhavala
Data last updated:
Ravimohan Dhavala has 15 years in corporate governance. Holds Whole-Time Director role. Currently with 1 company, including Genome Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Genome Therapeutics Private Limited at ₹5.47 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Genome Therapeutics Private Limited U24232TG2011PTC075543 | Whole-Time Director | 15 Jul 2011 | 2011 | ₹5.47 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravimohan Dhavala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravimohan Dhavala
Ravimohan Dhavala has 15 years in corporate governance. Holds Whole-Time Director role. Currently with 1 company, including Genome Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Genome Therapeutics Private Limited at ₹5.47 Cr (FY 2025).
Ravimohan Dhavala is associated with 1 company as Whole-Time Director, including Genome Therapeutics Private Limited (₹5.47 Cr).
Ravimohan Dhavala has expertise in General Business.
Ravimohan Dhavala has 15 years in corporate governance.
By reported revenue, the largest current company of Ravimohan Dhavala is Genome Therapeutics Private Limited, with revenue of ₹5.47 Cr (FY 2025).
Ravimohan Dhavala currently holds positions at 1 company: Genome Therapeutics Private Limited (₹5.47 Cr).